PACAP and its receptors in migraine pathophysiology: Commentary on Walker et al., Br J Pharmacol 171: 1521–1533

No abstract is available for this paper.

• Publication year

  2015

• Venue

  British Journal of Pharmacology

• Publication date

  2015-10-01

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1111/bph.12772PMID 24826981PMCID PMC4594281
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38.

  2014cited by this paper
• PACAP receptor pharmacology and agonist bias: analysis in primary neurons and glia from the trigeminal ganglia and transfected cells

  2014cited by this paper
• VIP/PACAP receptors in cerebral arteries of rat: characterization, localization and relation to intracellular calcium.

  2013cited by this paper
• Alternative Splicing of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1: Mechanisms of Fine Tuning of Brain Activity

  2013cited by this paper
• The Concise Guide to Pharmacology 2013/14: G Protein-Coupled Receptors

  2013cited by this paper
• Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients

  2013cited by this paper
• Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice

  2012cited by this paper
• Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide: IUPHAR Review 1

  2012cited by this paper
• Calcitonin gene-related peptide and its receptor components in the human sphenopalatine ganglion -- interaction with the sensory system.

  2012cited by this paper
• Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion.

  2012cited by this paper
• Diencephalic and brainstem mechanisms in migraine

  2011cited by this paper
• PACAP38 induces migraine-like attacks in patients with migraine without aura.

  2009cited by this paper
• VPAC and PAC receptors: From ligands to function.

  2009cited by this paper
• Novel stable PACAP analogs with potent activity towards the PAC1 receptor.

  2008cited by this paper
• Neurobiology in primary headaches.

  2005cited by this paper
• Neurotransmitters co-existing with VIP or PACAP.

  2004cited by this paper
• Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia

  2002cited by this paper
• Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.

  2000cited by this paper
• Cerebral Blood Flow Velocities are Reduced During Attacks of Unilateral Migraine Without Aura

  1995cited by this paper

• From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment

  2023cites this paper
• Emerging drugs for migraine treatment: an update

  2018cites this paper
• Kynurenines and PACAP in Migraine: Medicinal Chemistry and Pathogenetic Aspects.

  2017cites this paper
• Regulation Of Middle Meningeal Artery Diameter by Pacap and ATP-Sensitive Potassium Channels

  2016cites this paper
• PACAP Regulation of Vascular Tone: Differential Mechanism Among Vascular Beds

  2016cites this paper
• Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier.

  2015cites this paper
• The therapeutic potential of novel anti-migraine acute therapies

  2015cites this paper
• Stress-Induced Pain: A Target for the Development of Novel Therapeutics

  2014cites this paper